Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Stem Cell Therapy Rebuilds Heart Muscle in Primates

Published: Tuesday, May 13, 2014
Last Updated: Tuesday, May 13, 2014
Bookmark and Share
Human embryonic stem cells used to regenerate damaged primate hearts.

Scientists used human embryonic stem cells to regenerate damaged primate hearts. The strategy might one day be used to repair human hearts, but challenges still need to be overcome.

Damage to the heart-such as that caused by a heart attack-isn’t easy to mend. The heart’s muscle cells, called cardiomyocytes, don’t readily replenish themselves. After a typical heart attack, an estimated billion cardiomyocytes die. This jeopardizes heart function and can lead to chronic heart failure and possibly death.

Scientists have been searching for innovative ways to replenish damaged heart tissue. Human embryonic stem cells have proven promising in small animal models. These cells have the potential to develop into any cell type in the body.

Derivatives of the cells are already being tested in people for retinal diseases and spinal cord injury. However, cardiac repair requires much larger numbers of cells. The approaches developed in small animals also need to be tested in larger, more clinically relevant animals.

A research team led by Dr. Charles Murry at the University of Washington set out to test whether an approach they were developing could be scaled up and used in a large animal model. Their work was funded in part by NIH’s National Heart, Lung, and Blood Institute (NHLBI) and National Institute of General Medical Sciences (NIGMS). Results appeared online on April 30, 2014, in Nature.

The team first created cardiomyocytes from human embryonic stem cells that were genetically engineered to produce a fluorescent calcium indicator. This indicator allowed the researchers to track the calcium waves that mark the electrical activity of a beating heart. Pigtail macaques (Macaca nemestrina) with heart damage were treated to suppress their immune systems. Five days later, the cardiomyocytes were delivered in a surgical procedure to the damaged regions and surrounding border zones.

Over a 3-month period, the grafted cells infiltrated damaged heart muscle, matured, and organized into muscle fibers in all the monkeys who received the treatment. On average, the grafts replaced 40% of damaged tissue. Three-dimensional imaging showed that arteries and veins integrated into the grafts, suggesting the grafts could be long lasting. There was no evidence of graft rejection by the animals’ immune systems.

Calcium activity revealed that the grafts were electrically active and coupled to activity of the host heart. Grafts beat along with host muscle at rates of up to 240 beats per minute, the highest rate tested.

All the macaques that received the grafts showed transient arrhythmias-problems with the rate or rhythm of the heartbeat-that subsided by 4 weeks post-transplantation. The animals remained conscious and in no distress during periods of arrhythmia, but this problem will need to be addressed before the approach could be tested in humans.

“Before this study, it was not known if it is possible to produce sufficient numbers of these cells and successfully use them to remuscularize damaged hearts in a large animal whose heart size and physiology is similar to that of the human heart,” Murry says.

While several obstacles still need to be addressed, these experiments support the idea that human cardiomyocyte transplantation therapy may be feasible.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,900+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Gene Editing Corrects Sickle Cell Mutation
Researchers demonstrate a potential pathway to developing gene-editing treatments for sickle cell disease.
Wednesday, October 26, 2016
$12.4M Awarded to Neural Regeneration Projects
The National Institutes of Health will fund six projects to identify biological factors that influence neural regeneration.
Friday, September 02, 2016
Stem Cell Therapy Heals Injured Mouse Brain
A team of researchers has developed a therapeutic technique that dramatically increases the production of nerve cells in mice with stroke-induced brain damage.
Tuesday, August 23, 2016
Stem Cells Grown On Scaffold Mimic Hip Joint Cartilage
Adult fat-derived stem cells grown on a 3-D scaffold that mimicked a hip joint surface formed cartilage and maintained the correct shape.
Wednesday, August 10, 2016
Using Animal Embryos Containing Human Cells
With recent advances in stem cell and gene editing technologies, an increasing number of researchers are interested in growing human tissues and organs in animals by introducing pluripotent human cells into early animal embryos.
Monday, August 08, 2016
Treatment Advancement for Gaucher and Parkinson's Diseases
NIH scientists identify molecule that may act as a possible treatment of neurological diseases.
Wednesday, July 13, 2016
NIH Funds Million-Person Medicine Study
NIH announces $55million in awards to build foundations for ambitious Cohort Program that aims to engage 1 million participants in lifestyle, environments and genetics research.
Friday, July 08, 2016
Manufactured Stem Cells To Advance Clinical Research
Clinical-grade cell line will enable development of new therapies and accelerate early-stage clinical research.
Tuesday, June 28, 2016
NIH Funds Biobank To Support Precision Medicine Initiative Cohort Program
$142 million over five years will be awarded to the Mayo Clinic to establish the world’s largest research-cohort biobank for the PMI Cohort Program
Friday, May 27, 2016
Molecule Proves Key to Brain Repair After Stroke
Scientists found that a molecule known as growth and differentiation factor 10 (GDF10) plays a key role in repair mechanisms following stroke.
Tuesday, November 10, 2015
A Patient’s Budding Cortex — In A Dish?
Networking neurons thrive in 3-D human “organoid”
Friday, May 29, 2015
Drugs that Activate Brain Stem Cells May Reverse Multiple Sclerosis
NIH-funded study identifies over-the-counter compounds that may replace damaged cells.
Tuesday, April 21, 2015
Stem Cell Transplants May Halt Progression of Multiple Sclerosis
NIH-funded study yields encouraging early results.
Tuesday, December 30, 2014
Scientists Sniff Out Unexpected Role for Stem Cells in the Brain
NIH scientists find that restocking new cells in the brain’s center for smell maintains crucial circuitry.
Saturday, October 11, 2014
Suspect Gene Corrupts Neural Connections
“Diseases of synapses” demo’d in a dish - NIH-funded study.
Tuesday, August 19, 2014
Scientific News
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
BioCision Forms MedCision
The new company will focus on technologies for the management and automation of vital clinical processes.
Defining Immortality of Stem Cells
Researchers defined the mechanisms underlying increased protein quality control of pluripotent stem cells.
Enhancing CRISPR to Explore Further
Researchers have developed sOPTiKO, a more efficient and controllable CRISPR genome editing platform.
Regenerating Diseased Hearts
Researchers from the University of Otago have probed the potential of adult stem cell types to repair diseased hearts.
Stem Cells Police Themselves to Reduce Scarring
Scientists have discovered stem cells in muscle fibers change gene expressions to respond to injury.
Bright Red Fluorescent Protein Created
Scientists have created a bright red, fluorescent protein that could be used to track essential cellular processes.
Protein Self-Regulates Abundance
Researchers have uncovered how a protein, that plays a crucial role in embryonic stem cell renewal, is regulated.
Topical Immunotherapy Effective Against Early Skin Cancer
Combination of two commonly used drugs triggers immune response against precancerous skin lesions.
Factors Behind Suppression of Stem Cell Mobilization Revealed
The findings could lead to improvements in transplantation therapy.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!